BeStock  
Stocks › Biotechnology › PHAT

Phathom Pharmaceuticals PHAT

US equityMarket cap rank #3679Biotechnology
$6.81 +$0.03 (+0.44%)
Pre-market · Oct 8, 7:20 am ET · After hours $6.80 -0.15%
Open$6.87
Prev close$6.78
Day range$6.60 – $7.03
Volume1.63M
Market cap$550.94M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$19.29+183.3% vs. price
  • Buy 86%
  • Hold 14%
Low $10.00Now $6.81Avg $19.29High $26.00

Recent rating changes

The last 20 actions on file set price targets from $10.00 to $28.00, averaging $23.29.

DateFirmRatingTarget
21 Sep 2026 H.C. Wainwright BUY $26.00
9 Sep 2026 Leerink Partners HOLD $10.00
17 Aug 2026 Barclays BUY $14.00
31 Jul 2026 Craig-Hallum BUY $20.00
31 Jul 2026 Raymond James BUY $21.00
31 Jul 2026 Guggenheim BUY $22.00
31 Jul 2026 H.C. Wainwright BUY $26.00
30 Jul 2026 Needham BUY $22.00
21 Jul 2026 Needham BUY $28.00
21 Jul 2026 Guggenheim BUY $25.00
13 Jul 2026 Craig-Hallum BUY –
23 Jun 2026 Craig-Hallum BUY –
17 Jun 2026 H.C. Wainwright BUY $26.00
1 Jun 2026 Needham BUY $28.00
26 May 2026 Needham BUY $28.00
19 May 2026 Needham BUY $28.00
15 May 2026 Barclays BUY $18.00
1 May 2026 H.C. Wainwright BUY $26.00
30 Apr 2026 Needham BUY $28.00
30 Apr 2026 Goldman Sachs HOLD –

Discussion

No comments yet — be the first to weigh in on PHAT.

Leave a comment

Scroll to Top